Definium Therapeutics US, Inc.
Definium Therapeutics US, Inc.
Explore linked clinical trials.5 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Phase 3 Trial of DT120 for Major Depressive Disorder (Ascend) | depressive disorder, major depressive disorder, mood disorder, psychiatric disorder | Recruiting | Phase 3 | 2026-10-05 | NCT07592689 | |
| A Phase 3 Trial of DT120 for Generalized Anxiety Disorder (Voyage) | anxiety disorder, generalized anxiety disorder, psychiatric disorder | Active, not recruiting | Phase 3 | 2026-09-25 | NCT06741228 | |
| A Phase 3 Trial of MM120 for Generalized Anxiety Disorder (Panorama) | anxiety disorder, generalized anxiety disorder, psychiatric disorder | Active, not recruiting | Phase 3 | 2026-09-04 | NCT06809595 | |
| A Phase 2A Trial of DT402 for Autism Spectrum Disorder | atrial septal defect, autism spectrum disorder, neurodevelopmental disorder, pervasive developmental disorder, psychiatric disorder | Recruiting | Phase 2 | 2026-09-02 | NCT07303907 | |
| A Phase 3 Trial of DT120 for Major Depressive Disorder (Emerge) | depressive disorder, major depressive disorder, mood disorder, psychiatric disorder | Active, not recruiting | Phase 3 | 2026-08-28 | NCT06941844 |